Clinical Research Directory
Browse clinical research sites, groups, and studies.
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
Sponsor: Johns Hopkins University
Summary
In a residency clinic in Baltimore, the investigators propose to conduct a pilot RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control. With a sample of participants from the residency clinic (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. The investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.
Official title: C-Raven: Pilot RCT of an Avatar-delivered Computerized Intervention for Tobacco Cessation With Community Health Worker Linkage to Lung Cancer Screening in Baltimore City (FY26)
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-12-10
Completion Date
2027-06-30
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
C-Raven Virtual Tobacco Cessation Counseling
A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Nicotine Replacement Product
Participants will be offered up to a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Community Health Worker
A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Lung Cancer Screening
After participating in shared decision-making, eligible participants will be referred to primary care physician or existing specialist to complete lung cancer screening.
Locations (1)
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States